News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
307,385 Results
Type
Article (8445)
Company Profile (101)
Press Release (298839)
Section
Business (105629)
Career Advice (636)
Deals (18382)
Drug Delivery (20)
Drug Development (31882)
Employer Resources (42)
FDA (4729)
Job Trends (5819)
News (160548)
Policy (10180)
Tag
2024 BioCapital Digital (4)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (2)
2026 Biotech Bay Standard (1)
Academia (532)
Adcomms (4)
Allergies (22)
Alliances (22579)
ALS (38)
Alzheimer's disease (469)
Antibody-drug conjugate (ADC) (32)
Approvals (4753)
Artificial intelligence (73)
Autoimmune disease (7)
Automation (5)
Bankruptcy (126)
Best Places to Work (4435)
BIOSECURE Act (13)
Biosimilars (17)
Biotechnology (100)
Bladder cancer (22)
Brain cancer (12)
Breast cancer (100)
Cancer (797)
Cardiovascular disease (31)
Career advice (554)
Career pathing (6)
CAR-T (68)
Cell therapy (213)
Cervical cancer (7)
Clinical research (26282)
Collaboration (337)
Compensation (215)
Complete response letters (3)
COVID-19 (660)
CRISPR (13)
C-suite (146)
Cystic fibrosis (39)
Data (884)
Depression (12)
Diabetes (79)
Diagnostics (2484)
Digital health (4)
Diversity, equity & inclusion (15)
Drug discovery (48)
Drug pricing (11)
Drug shortages (2)
Duchenne muscular dystrophy (25)
Earnings (46089)
Editorial (5)
Employer branding (6)
Employer resources (43)
Events (54118)
Executive appointments (421)
FDA (5136)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (334)
Gene editing (30)
Generative AI (6)
Gene therapy (102)
GLP-1 (182)
Government (681)
Guidances (22)
Healthcare (5941)
Huntington's disease (6)
IgA nephropathy (7)
Immunology and inflammation (29)
Indications (13)
Infectious disease (699)
Inflammatory bowel disease (66)
Inflation Reduction Act (3)
Influenza (19)
Intellectual property (43)
Interviews (68)
IPO (9309)
IRA (7)
Job creations (1591)
Job search strategy (512)
Kidney cancer (6)
Labor market (11)
Layoffs (126)
Leadership (4)
Legal (2789)
Liver cancer (20)
Lung cancer (78)
Lymphoma (59)
Management (13)
Manufacturing (111)
MASH (30)
Medical device (4102)
Medtech (4103)
Mergers & acquisitions (9373)
Metabolic disorders (200)
Multiple sclerosis (26)
NASH (6)
Neurodegenerative disease (23)
Neuropsychiatric disorders (4)
Neuroscience (653)
NextGen: Class of 2025 (2250)
Non-profit (920)
Northern California (1346)
Now hiring (6)
Obesity (97)
Opinion (63)
Ovarian cancer (43)
Pain (26)
Pancreatic cancer (26)
Parkinson's disease (51)
Partnered (8)
Patents (66)
Patient recruitment (45)
Peanut (15)
People (33250)
Pharmaceutical (12)
Pharmacy benefit managers (1)
Phase I (8923)
Phase II (11882)
Phase III (7951)
Pipeline (636)
Podcasts (2)
Policy (27)
Postmarket research (751)
Preclinical (3696)
Press Release (72)
Prostate cancer (39)
Psychedelics (5)
Radiopharmaceuticals (140)
Rare diseases (118)
Real estate (2868)
Recruiting (17)
Regulatory (7261)
Reports (18)
Research institute (534)
Resumes & cover letters (88)
Rett syndrome (2)
RSV (4)
Schizophrenia (33)
Series A (57)
Series B (41)
Service/supplier (2)
Sickle cell disease (17)
Southern California (1132)
Special edition (2)
Spinal muscular atrophy (60)
Sponsored (7)
Startups (1685)
State (1)
Stomach cancer (3)
Supply chain (21)
The Weekly (2)
United States (10613)
Vaccines (105)
Venture capitalists (9)
Webinars (7)
Weight loss (37)
Women's health (5)
Worklife (2)
Date
Today (118)
Last 7 days (378)
Last 30 days (1371)
Last 365 days (16377)
2025 (3897)
2024 (17207)
2023 (19657)
2022 (26037)
2021 (27324)
2020 (24229)
2019 (17579)
2018 (13597)
2017 (14002)
2016 (13026)
2015 (16257)
2014 (12821)
2013 (10431)
2012 (11334)
2011 (12050)
2010 (11620)
Location
Africa (284)
Alabama (36)
Alaska (2)
Arizona (78)
Arkansas (3)
Asia (17107)
Australia (3133)
California (2973)
Canada (992)
China (155)
Colorado (95)
Connecticut (120)
Delaware (43)
Europe (37128)
Florida (356)
Georgia (51)
Idaho (29)
Illinois (209)
India (8)
Indiana (136)
Iowa (2)
Japan (76)
Kansas (34)
Kentucky (10)
Louisiana (6)
Maine (39)
Maryland (367)
Massachusetts (2344)
Michigan (142)
Minnesota (188)
Mississippi (1)
Missouri (28)
Montana (16)
Nebraska (13)
Nevada (25)
New Hampshire (20)
New Jersey (728)
New Mexico (10)
New York (762)
North Carolina (499)
North Dakota (5)
Northern California (1346)
Ohio (83)
Oklahoma (7)
Oregon (7)
Pennsylvania (599)
Puerto Rico (3)
Rhode Island (12)
South America (428)
South Carolina (5)
Southern California (1132)
Tennessee (47)
Texas (356)
Utah (71)
Virginia (48)
Washington D.C. (13)
Washington State (378)
West Virginia (2)
Wisconsin (23)
307,385 Results for "generex biotechnology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
20 min read
Press Releases
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
February 12, 2025
·
1 min read
Press Releases
Adnexus Biotechnologies Inc. Announces a Merger Agreement to Acquire Sanctum Therapeutics Corporation
November 6, 2024
·
5 min read
Business
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
Business
Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical
Generex Biotechnology Corporation announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc.
July 26, 2021
·
4 min read
Press Releases
Momentum Biotechnologies Announces Acquisition of OmicScouts
March 5, 2025
·
4 min read
Business
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced results for the first quarter ended 2024 and provided a corporate update.
May 29, 2024
·
18 min read
Press Releases
Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 31, 2024
·
17 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Anbio Biotechnology Announces Closing of Initial Public Offering
February 21, 2025
·
4 min read
1 of 30,739
Next
